Viewing Study NCT06902857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-01-03 @ 8:22 AM
Study NCT ID: NCT06902857
Status: RECRUITING
Last Update Posted: 2025-04-03
First Post: 2025-03-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
None Cardiovascular Complication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None high-sensitivity cardiac troponin I View
None N-terminal pro-B-natriuretic peptide View
None soluble suppression of tumorigenesis-2 View
None mortality risk View
None diabetes complications View